Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases
Sergio Mallart(Sanofi (France)), Stéphane Illiano(Délégation Paris 5), Laura Orsatti(IRBM Science Park), Alain Corbier(Sanofi (France)), Xavier Chénedé(Sanofi (France)), Frank Marguet(Sanofi (France)), Daniela Roversi(IRBM Science Park), Claire Minoletti(Sanofi (France)), Denis Brasseur(Sanofi (France)), Bernard Maillère(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Olivier Duclos(Sanofi (France)), Edith Monteagudo(IRBM Science Park), Bruno Poirier(Sanofi (France)), Fulvia Caretti(IRBM Science Park), Annalise Di Marco(IRBM Science Park), Laurence Gauzy‐Lazo(Sanofi (France)), Aurélien Azam(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Maria Veneziano(IRBM Science Park), Raffaele Ingenito, Elisabetta Bianchi(IRBM Science Park), Alessia Santoprete(IRBM Science Park), Vincent Gervat(Sanofi (France)), Alberto Bresciani(University of Bergamo), Paola Magotti(IRBM Science Park), Simone Esposito(IRBM Science Park), Olivier Pasquier(Sanofi (France)), Philip Janiak(Hôpital Lariboisière)
Cited by 1
Related Papers
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
|Circulation|2023|141
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease
|Journal of Clinical Investigation|2019|101
Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice
|Journal of Cardiovascular Pharmacology|2001|93